According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

The ELEVATUM study's initial data showed vision improvements in patients who were given Vabysmo every eight weeks for a year.

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

CHICAGO, CA, UNITED STATES, October 18, 2024 /EINPresswire / -- The Global Age-Related Macular Degeneration (AMD) <a target=_blank href= ...

Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.

Age-related macular degeneration is the most common cause of choroidal neovascularization (CNV) and it is an important cause of vision loss in the ageing population. CNV is a multifactorial ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...

Metformin shows promise as a potential therapy for limiting the risk of developing age-related macular degeneration.

A new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...